South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

novartis south africa (pty) ltd - injection - see ingredients - each 1,0 ml solution contains ranibizumab 10,0 mg

Canada - English - Health Canada

apotex inc - bevacizumab - solution - 100mg - bevacizumab 100mg - antineoplastic agents

Canada - English - Health Canada

apotex inc - bevacizumab - solution - 400mg - bevacizumab 400mg - antineoplastic agents

Canada - English - Health Canada

biosimilar collaborations ireland limited - bevacizumab - solution - 400mg - bevacizumab 400mg - antineoplastic agents

Canada - English - Health Canada

biosimilar collaborations ireland limited - bevacizumab - solution - 100mg - bevacizumab 100mg - antineoplastic agents

Canada - English - Health Canada

samsung bioepis co., ltd - bevacizumab - solution - 100mg - bevacizumab 100mg

Canada - English - Health Canada

samsung bioepis co., ltd - bevacizumab - solution - 400mg - bevacizumab 400mg

European Union - English - EMA (European Medicines Agency)

rotterdam biologics b.v. - bevacizumab - wet macular degeneration - ophthalmologicals - treatment of neovascular (wet) age-related macular degeneration (amd)

Canada - English - Health Canada

celltrion healthcare co ltd - bevacizumab - solution - 100mg - bevacizumab 100mg

Canada - English - Health Canada

celltrion healthcare co ltd - bevacizumab - solution - 400mg - bevacizumab 400mg